279 related articles for article (PubMed ID: 33007125)
1. Activation of β2-adrenergic receptor signals suppresses mesenchymal phenotypes of oral squamous cell carcinoma cells.
Sakakitani S; Podyma-Inoue KA; Takayama R; Takahashi K; Ishigami-Yuasa M; Kagechika H; Harada H; Watabe T
Cancer Sci; 2021 Jan; 112(1):155-167. PubMed ID: 33007125
[TBL] [Abstract][Full Text] [Related]
2. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow-Derived Mesenchymal Stem Cells Promoted Cutaneous Wound Healing by Regulating Keratinocyte Migration via β
Huo J; Sun S; Geng Z; Sheng W; Chen R; Ma K; Sun X; Fu X
Mol Pharm; 2018 Jul; 15(7):2513-2527. PubMed ID: 29757659
[TBL] [Abstract][Full Text] [Related]
4. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of β-Adrenergic Receptors and the Suppressive Effect of β
Zhang C; Liao X; Ma Z; Liu S; Fang F; Mai H
J Oral Maxillofac Surg; 2020 Oct; 78(10):1871.e1-1871.e23. PubMed ID: 32640209
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
[TBL] [Abstract][Full Text] [Related]
7. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
[TBL] [Abstract][Full Text] [Related]
10. The stress hormone norepinephrine promotes tumor progression through β2-adrenoreceptors in oral cancer.
Zhang B; Wu C; Chen W; Qiu L; Li S; Wang T; Xie H; Li Y; Li C; Li L
Arch Oral Biol; 2020 May; 113():104712. PubMed ID: 32234582
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
12. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
13. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
17. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
18. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
20. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]